Titan Pharmaceuticals (TTNP)
(Delayed Data from NSDQ)
$5.84 USD
-0.14 (-2.37%)
Updated Jul 25, 2024 03:42 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
TTNP 5.84 -0.14(-2.37%)
Will TTNP be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TTNP based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for TTNP
Earnings week ahead: NVIDIA, Target, Zoom Video, Snowflake and more
TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q4 2023
TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q1 2024
Titan Pharmaceuticals: Q1 Earnings Snapshot
12 Health Care Stocks Moving In Monday's Intraday Session